During the past decade, Nemocnice Teplice conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Teplice" #1 sponsor was "Biogen" with 2 trials, followed by "Genzyme, a Sanofi Company" with 2 trials sponsored, "Jazz Pharmaceuticals" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Teplice" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Teplice" are "Multiple Sclerosis" (8 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Relapsing-Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Nemocnice Teplice" in a lesser frequency.

Most popular intervention types in "Nemocnice Teplice" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Interferon beta-1a" (2 trials), "Mavenclad®" (2 trials), "Nabiximols" (2 trials) and "Alemtuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Teplice" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Teplice". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Nemocnice Teplice, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Teplice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".